AtriCure, Inc. (ATRC)
49.27
+0.29
(+0.59%)
USD |
NASDAQ |
Aug 24, 16:00
49.27
0.00 (0.00%)
After-Hours: 20:00
AtriCure Price to Book Value : 4.853 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 4.824 |
| August 20, 2026 | 4.677 |
| August 19, 2026 | 4.689 |
| August 18, 2026 | 4.507 |
| August 17, 2026 | 4.409 |
| August 14, 2026 | 4.363 |
| August 13, 2026 | 4.283 |
| August 12, 2026 | 4.290 |
| August 11, 2026 | 4.230 |
| August 10, 2026 | 4.101 |
| August 07, 2026 | 4.076 |
| August 06, 2026 | 3.889 |
| August 05, 2026 | 3.875 |
| August 04, 2026 | 3.841 |
| August 03, 2026 | 3.814 |
| July 31, 2026 | 3.719 |
| July 30, 2026 | 3.954 |
| July 29, 2026 | 4.027 |
| July 28, 2026 | 3.915 |
| July 27, 2026 | 3.680 |
| July 24, 2026 | 3.451 |
| July 23, 2026 | 3.250 |
| July 22, 2026 | 3.301 |
| July 21, 2026 | 3.398 |
| July 20, 2026 | 3.424 |
| Date | Value |
|---|---|
| July 17, 2026 | 3.442 |
| July 16, 2026 | 3.508 |
| July 15, 2026 | 3.402 |
| July 14, 2026 | 3.380 |
| July 13, 2026 | 3.427 |
| July 10, 2026 | 3.376 |
| July 09, 2026 | 3.404 |
| July 08, 2026 | 3.315 |
| July 07, 2026 | 3.230 |
| July 06, 2026 | 3.190 |
| July 02, 2026 | 3.131 |
| July 01, 2026 | 2.928 |
| June 30, 2026 | 2.756 |
| June 29, 2026 | 2.956 |
| June 26, 2026 | 3.108 |
| June 25, 2026 | 2.897 |
| June 24, 2026 | 2.912 |
| June 23, 2026 | 2.929 |
| June 22, 2026 | 2.929 |
| June 18, 2026 | 2.966 |
| June 17, 2026 | 2.793 |
| June 16, 2026 | 2.881 |
| June 15, 2026 | 2.881 |
| June 12, 2026 | 2.965 |
| June 11, 2026 | 2.926 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Boston Scientific Corp. | 2.844 |
| Abbott Laboratories | 3.950 |
| AngioDynamics, Inc. | 3.852 |
| Alphatec Holdings, Inc. | -- |
| Baxter International, Inc. | 2.207 |
Price to Book Value Related Metrics
| PE Ratio | 227.68 |
| PS Ratio | 4.191 |
| Price to Free Cash Flow | 44.94 |
| Price | 49.27 |
| Earnings Yield | 0.44% |
| Market Cap | 2.506B |
| Operating PE Ratio | 171.85 |
| Normalized PE Ratio | 213.20 |